(4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide

C17H21N5O2S — CID 97367075

IUPAC(4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide
SMILESO=C(Nc1cnccn1)[C@@H]1CCO[C@@H]2CCN(Cc3nccs3)C[C@H]21
InChIInChI=1S/C17H21N5O2S/c23-17(21-15-9-18-3-4-19-15)12-2-7-24-14-1-6-22(10-13(12)14)11-16-20-5-8-25-16/h3-5,8-9,12-14H,1-2,6-7,10-11H2,(H,19,21,23)/t12-,13+,14-/m1/s1
InChIKeyMLROSNFXGCHFDL-HZSPNIEDSA-N
MW359.46 g/mol
LogP1.80
Rot. Bonds4

About (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide

(4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide (PubChem CID 97367075) has the molecular formula C17H21N5O2S and a molecular weight of 359.46 g/mol. Its IUPAC name is (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide.

Molecular Properties

Compound Name(4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide
PubChem CID97367075
Molecular FormulaC17H21N5O2S
Molecular Weight359.46 g/mol
Exact Mass359.14
IUPAC Name(4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide
SMILESO=C(Nc1cnccn1)[C@@H]1CCO[C@@H]2CCN(Cc3nccs3)C[C@H]21
InChIInChI=1S/C17H21N5O2S/c23-17(21-15-9-18-3-4-19-15)12-2-7-24-14-1-6-22(10-13(12)14)11-16-20-5-8-25-16/h3-5,8-9,12-14H,1-2,6-7,10-11H2,(H,19,21,23)/t12-,13+,14-/m1/s1
InChIKeyMLROSNFXGCHFDL-HZSPNIEDSA-N
XLogP1.80
TPSA80.24 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500359.46
LogP ≤ 51.80
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide?
The IUPAC name of (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide (CID 97367075) is (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide.
What is the SMILES notation for (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide?
The canonical SMILES for (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide is O=C(Nc1cnccn1)[C@@H]1CCO[C@@H]2CCN(Cc3nccs3)C[C@H]21.
What is the InChIKey of (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide?
The InChIKey is MLROSNFXGCHFDL-HZSPNIEDSA-N. The full InChI is InChI=1S/C17H21N5O2S/c23-17(21-15-9-18-3-4-19-15)12-2-7-24-14-1-6-22(10-13(12)14)11-16-20-5-8-25-16/h3-5,8-9,12-14H,1-2,6-7,10-11H2,(H,19,21,23)/t12-,13+,14-/m1/s1.
What are the key properties of (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide?
(4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide has a molecular weight of 359.46 g/mol, XLogP of 1.80, 4 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (4R,4aR,8aR)-N-pyrazin-2-yl-6-(1,3-thiazol-2-ylmethyl)-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyridine-4-carboxamide is sourced from PubChem (CID 97367075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).